<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>汇聚南药 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-06T20:24:40+08:00</updated>
  <subtitle>为中国药科大学毕业的各届校友搭建的信息交流平台。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>恒瑞医药：50周年庆！5000亿市值！一大批创新药在路上！</title>
    <updated>2020-11-06T19:25:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/zjCy54nYYgglfhG2HrakXg</id>
    <link href="https://mp.weixin.qq.com/s/zjCy54nYYgglfhG2HrakXg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>专家谈新修订《药品质量抽查检验管理办法》</title>
    <updated>2020-11-06T19:25:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/WoflnIC3kCaJj5MQuJAM4A</id>
    <link href="https://mp.weixin.qq.com/s/WoflnIC3kCaJj5MQuJAM4A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>齐鲁制药抗肿瘤药注射用硼替佐米通过一致性评价</title>
    <updated>2020-11-06T19:25:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/d-S5i_WNWTy5J_AE30QtQw</id>
    <link href="https://mp.weixin.qq.com/s/d-S5i_WNWTy5J_AE30QtQw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>财报 | 瑞德西韦三季度创收8.7亿美元，吉利德优先审评券遭质疑</title>
    <updated>2020-11-06T19:25:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/DkXCE7YeLXfMii-E7x8v-w</id>
    <link href="https://mp.weixin.qq.com/s/DkXCE7YeLXfMii-E7x8v-w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>阿斯利康热销药品被重点监控，你家的品种还好吗？</title>
    <updated>2020-11-06T19:25:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/90EMV3qrfYmjbrbENEoJ-Q</id>
    <link href="https://mp.weixin.qq.com/s/90EMV3qrfYmjbrbENEoJ-Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速读社丨默沙东$27.5亿收购VelosBio 九州通重大人事变动</title>
    <updated>2020-11-06T19:25:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/YSZAz1YV0L68z80ZwXazJg</id>
    <link href="https://mp.weixin.qq.com/s/YSZAz1YV0L68z80ZwXazJg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>文献|儿童口服液体药物制剂的技术难点及研发策略分析</title>
    <updated>2020-11-06T19:25:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/Wlfqzew0tEOpH9mZigGCtA</id>
    <link href="https://mp.weixin.qq.com/s/Wlfqzew0tEOpH9mZigGCtA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>多家药企被处罚，一药企被连罚两次</title>
    <updated>2020-11-06T19:25:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/2db28ZHA761LekRh8lgxqg</id>
    <link href="https://mp.weixin.qq.com/s/2db28ZHA761LekRh8lgxqg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药圈炸锅！国家的“灵魂谈判”又来了，1.3万的心脏支架谈到700元，将为老百姓节约109亿</title>
    <updated>2020-11-05T19:18:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/vR7juPmOeJkL54AUloC1RA</id>
    <link href="https://mp.weixin.qq.com/s/vR7juPmOeJkL54AUloC1RA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药股未来投资机会，在这三条主线！</title>
    <updated>2020-11-05T19:18:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/zG-jU7ynXczP_tL4QSDMjQ</id>
    <link href="https://mp.weixin.qq.com/s/zG-jU7ynXczP_tL4QSDMjQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中国药科大学北京校友会举办“CPUBJ投融资”主题沙龙--持续创新持续进步</title>
    <updated>2020-11-05T19:18:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/s2Cdk_IlX-cCJ0fclIKMCg</id>
    <link href="https://mp.weixin.qq.com/s/s2Cdk_IlX-cCJ0fclIKMCg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国采中标产品“替代监测大目录”发布，影响几何？</title>
    <updated>2020-11-05T19:18:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/LsHxc0kXROAttjCu9Qg-xw</id>
    <link href="https://mp.weixin.qq.com/s/LsHxc0kXROAttjCu9Qg-xw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国际化是大势所趋：今年我国药企已获82个ANDA批文</title>
    <updated>2020-11-05T19:18:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/b3zC6jXeV8qESFLHneKr9Q</id>
    <link href="https://mp.weixin.qq.com/s/b3zC6jXeV8qESFLHneKr9Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新药 | 助力中药质量提升 CDE重磅发布全生命周期药学研究策略</title>
    <updated>2020-11-05T19:18:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/z1erNP2cyn6NCLVD6uPRmw</id>
    <link href="https://mp.weixin.qq.com/s/z1erNP2cyn6NCLVD6uPRmw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>省级集采，一线强省：浙江8个，河南31个， 江苏与原研药价差大的品种……</title>
    <updated>2020-11-05T19:18:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/G51bDfNzseNjE5Lv1M7_2g</id>
    <link href="https://mp.weixin.qq.com/s/G51bDfNzseNjE5Lv1M7_2g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>央视曝光：超30种中药材涨价</title>
    <updated>2020-11-05T19:18:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/ygVPwCWdYtinO62TFWR8RQ</id>
    <link href="https://mp.weixin.qq.com/s/ygVPwCWdYtinO62TFWR8RQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>不得“一刀切”停用未中选药品，山东、北京等地发文（附全国落地情况）</title>
    <updated>2020-11-04T18:54:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/fzSZ4fY3v0OD5YZQFEQXbw</id>
    <link href="https://mp.weixin.qq.com/s/fzSZ4fY3v0OD5YZQFEQXbw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>111个品种今年底踢出江苏省医保增补目录</title>
    <updated>2020-11-04T18:54:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/yFlGOdq4el98Zu_-7nGBlA</id>
    <link href="https://mp.weixin.qq.com/s/yFlGOdq4el98Zu_-7nGBlA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>M司新公司有3个月工资欢迎奖......</title>
    <updated>2020-11-04T18:54:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/HCMZHgndXc_QlaLje0C-Bg</id>
    <link href="https://mp.weixin.qq.com/s/HCMZHgndXc_QlaLje0C-Bg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>今日，百济神州引进的抗癌新药迪妥昔单抗上市申请获CDE受理</title>
    <updated>2020-11-04T18:54:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/v4UiHNtzFobfqB3q-UnVJw</id>
    <link href="https://mp.weixin.qq.com/s/v4UiHNtzFobfqB3q-UnVJw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>